second malignancy
Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.
Collectively, our results support the idea that modulation of <span class="gene" id="21991345-9-62-67">RAD9A</span> and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a <span class="disease" id="21991345-9-159-176">second malignancy</span> in childhood cancer patients.